Activities of PDGF-BB/PDGFRβ signalling are strongly implicated in the pathogenesis of PAH in patients and animal models by initiating and maintaining underlying pulmonary vascular remodelling [27]. This evidence concerns the gene PDGFRB and pulmonary arterial hypertension.